GRAIL, Inc. (NL0)
FSX
Real-time Data
06:00 AM
Day's Range
116.6552 wk Range
34.00Overview - NL0 - GRAIL, Inc.
Key Statistics
Valuation
Enterprise Value
3.01B
P/E (Trailing)
‪-9.60‬
PEG Ratio
‪0.49‬
Price / Sales (TTM)
‪25.45‬
Price / Book
‪1.69‬
EV / EBITDA
‪-9.07‬
Profitability
Gross Margin
‪-28.12%‬
Profit Margin
‪-236.94%‬
Operating Margin
‪-331.99%‬
Return on Assets
‪-12.03%‬
Return on Equity
‪-16.12%‬
Ownership
Shares Outstanding
44.66M
Float
34.30M
Held by Insiders
‪4.99%‬
Held by Institutions
‪86.30%‬
Price stats
Beta
‪3.25‬
50-Day Avg
‪63.86‬
200-Day Avg
‪60.07‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - NL0 - GRAIL, Inc.
Peers - NL0 - GRAIL, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on FSX.
- NL0FSXGRAIL, Inc.4.76BMarket Cap+61.11%52-week change-9.60P/E (Trailing)‪-236.94%‬Profit Margin
- TN8FSXThermo Fisher Scientific Inc.218.52BMarket Cap+33.54%52-week change36.19P/E (Trailing)‪15.03%‬Profit Margin
- TN80FSXThermo Fisher Scientific CDR (CAD Hedged)185.99BMarket Cap+15.94%52-week change31.86P/E (Trailing)‪15.03%‬Profit Margin
- DAPFSXDanaher Corp.132.16BMarket Cap+3.30%52-week change37.98P/E (Trailing)‪15.94%‬Profit Margin
- SONAFSXSony Group Corp. Sponsored ADR116.90BMarket Cap-24.00%52-week change19.42P/E (Trailing)‪-1.74%‬Profit Margin
- WX8FSXWuXi AppTec Co., Ltd.71.50BMarket Cap+44.40%52-week change3.23P/E (Trailing)‪42.25%‬Profit Margin
- 45EFSXNatera, Inc.52.13BMarket Cap+76.22%52-week change-237.96P/E (Trailing)‪-7.10%‬Profit Margin
Profile Summary - NL0 - GRAIL, Inc.
About
GRAIL, Inc. is a commercial-stage healthcare company focused on multi-cancer early detection testing and services. Its core offering is Galleri, a blood-based screening test designed to detect multiple cancer types before symptoms appear, supporting earlier clinical evaluation and diagnosis. The company uses…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
